These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Histopathology of a benign bile duct lesion in the liver: Morphologic mimicker or precursor of intrahepatic cholangiocarcinoma. Lee KB Clin Mol Hepatol; 2016 Sep; 22(3):400-405. PubMed ID: 27729636 [TBL] [Abstract][Full Text] [Related]
23. Characterization of a new rat cell line established from 2'AAF-induced combined hepatocellular cholangiocellular carcinoma. Gil-Benso R; Martinez-Lorente A; Pellin-Perez A; Navarro-Fos S; Gregori-Romero MA; Carda C; Callaghan R; Peydro-Olaya A; Llombart-Bosch A In Vitro Cell Dev Biol Anim; 2001 Jan; 37(1):17-25. PubMed ID: 11249201 [TBL] [Abstract][Full Text] [Related]
24. NTP 3-month toxicity studies of estragole (CAS No. 140-67-0) administered by gavage to F344/N rats and B6C3F1 mice. Bristol DW Toxic Rep Ser; 2011 Jan; (82):1-111. PubMed ID: 21445103 [TBL] [Abstract][Full Text] [Related]
25. Intrahepatic cholangiocarcinoma: new insights in pathology. Sempoux C; Jibara G; Ward SC; Fan C; Qin L; Roayaie S; Fiel MI; Schwartz M; Thung SN Semin Liver Dis; 2011 Feb; 31(1):49-60. PubMed ID: 21344350 [TBL] [Abstract][Full Text] [Related]
26. A trial to find appropriate animal models of dichloropropane-induced cholangiocarcinoma based on the hepatic distribution of glutathione S-transferases. Zhang L; Zong C; Ichihara S; Naito H; Toyokuni S; Kumagai S; Ichihara G J Occup Health; 2015; 57(6):548-54. PubMed ID: 26423826 [TBL] [Abstract][Full Text] [Related]
27. Histogenesis of cholangiofibrosis and well-differentiated cholangiocarcinoma in Syrian hamsters given 2-acetamidofluorene or 2-diacetamidofluorene. Reuber MD Gan; 1968 Jun; 59(3):239-46. PubMed ID: 5726265 [No Abstract] [Full Text] [Related]
28. [Experimental induction of biliary tract carcinoma associated with proliferative cholangitis in Syrian hamster]. Arisato H Hokkaido Igaku Zasshi; 1996 Sep; 71(5):623-36. PubMed ID: 8934206 [TBL] [Abstract][Full Text] [Related]
29. Imaging hamster model of bile duct cancer in vivo using fluorescent L-glucose derivatives. Yokoyama H; Sasaki A; Yoshizawa T; Kijima H; Hakamada K; Yamada K Hum Cell; 2016 Jul; 29(3):111-21. PubMed ID: 26842558 [TBL] [Abstract][Full Text] [Related]
30. Primary biliary malignant lymphoma clinically mimicking cholangiocarcinoma: a case report and review of the literature. Eliason SC; Grosso LE Ann Diagn Pathol; 2001 Feb; 5(1):25-33. PubMed ID: 11172204 [TBL] [Abstract][Full Text] [Related]
31. The expression of matrix metalloproteinases in intrahepatic cholangiocarcinoma, hilar (Klatskin tumor), middle and distal extrahepatic cholangiocarcinoma, gallbladder cancer, and ampullary carcinoma: role of matrix metalloproteinases in tumor progression and prognosis. Kirimlioğlu H; Türkmen I; Başsüllü N; Dirican A; Karadağ N; Kirimlioğlu V Turk J Gastroenterol; 2009 Mar; 20(1):41-7. PubMed ID: 19330734 [TBL] [Abstract][Full Text] [Related]
32. Induction of cholangiocarcinoma in the Golden Syrian hamster using methylazoxymethyl acetate. Imray CH; Newbold KM; Davis A; Lavelle-Jones M; Neoptolemos JP Eur J Surg Oncol; 1992 Aug; 18(4):373-8. PubMed ID: 1325925 [TBL] [Abstract][Full Text] [Related]
33. Proteomic analysis to identify plasma orosomucoid 2 and kinesin 18A as potential biomarkers of cholangiocarcinoma. Rucksaken R; Khoontawad J; Roytrakul S; Pinlaor P; Hiraku Y; Wongkham C; Pairojkul C; Boonmars T; Pinlaor S Cancer Biomark; 2012; 12(2):81-95. PubMed ID: 23396253 [TBL] [Abstract][Full Text] [Related]
34. Intestinal type cholangiocarcinoma of intrahepatic large bile duct associated with hepatolithiasis--a new histologic subtype for further investigation. Bae JY; Park YN; Nakanuma Y; Lee WJ; Kim JY; Park C Hepatogastroenterology; 2002; 49(45):628-30. PubMed ID: 12063956 [TBL] [Abstract][Full Text] [Related]
35. Histological type of intrahepatic cholangiocarcinoma differentiated by genetic alteration from AP-PCR fingerprint. Chuensumran U; Saelee P; Wongkham S; Pairojkul C; Chauin S; Petmitr S Asian Pac J Cancer Prev; 2011; 12(6):1377-80. PubMed ID: 22126467 [TBL] [Abstract][Full Text] [Related]
36. Hepatocarcinoma-intestine-pancreas/pancreatic associated protein (HIP/PAP) is expressed and secreted by proliferating ductules as well as by hepatocarcinoma and cholangiocarcinoma cells. Christa L; Simon MT; Brezault-Bonnet C; Bonte E; Carnot F; Zylberberg H; Franco D; Capron F; Roskams T; Bréchot C Am J Pathol; 1999 Nov; 155(5):1525-33. PubMed ID: 10550309 [TBL] [Abstract][Full Text] [Related]
37. Intrahepatic clear cell cholangiocarcinoma: immunohistochemical aspects in a very rare type of cholangiocarcinoma. Haas S; Gütgemann I; Wolff M; Fischer HP Am J Surg Pathol; 2007 Jun; 31(6):902-6. PubMed ID: 17527078 [TBL] [Abstract][Full Text] [Related]
38. p53 Mutations in human cholangiocarcinoma: a review. Khan SA; Thomas HC; Toledano MB; Cox IJ; Taylor-Robinson SD Liver Int; 2005 Aug; 25(4):704-16. PubMed ID: 15998419 [TBL] [Abstract][Full Text] [Related]